Short Sellers Up the Ante in Major Biotechs
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The August 31 short interest data have been compared with the previous report, and short interest in most…
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The August 31 short interest data have been compared with the previous report, and short interest in most…
The August 15 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
The latest monthly Merrill Lynch RIC Report is quite favorable on the health care sector as an opportunity for investors. Here we identify some of the top health care picks.
The July 31 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
The July 13 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.
Biogen released better-than-expected second-quarter financial results before the markets opened on Tuesday.
The top analyst upgrades, downgrades and other research calls from Monday included Apple, Biogen, BJ's Wholesale, ConocoPhillips, Honeywell, Schlumberger, Shopify and Spotify.
24/7 Wall St. has put together a preview of AbbVie, Eli Lilly, Gilead Sciences and some of the other, larger health care companies that are about to report their quarterly results.
The June 29 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
The top analyst upgrades, downgrades and other research calls from Tuesday include American Tower, AutoNation, Biogen, CarMax, Chipotle Mexican Grill, eBay, PG&E, Walgreens and Zions Bancorp.
Friday was a positive day for the broad U.S. markets, closing out an ultimately positive but shortened week. Crude oil bounced back on the day. The S&P 500 sectors were entirely positive.
The top analyst upgrades, downgrades and other research calls from Friday include Apple, Biogen, Costco, Kroger, Humana and Patterson-UTI.
Biogen shares jumped early on Friday after the firm, in conjunction with Eisai, announced positive results from a midstage Alzheimer’s study.
The June 15 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
Monday was a down day for the broad U.S. markets. The Nasdaq took another day off from hitting more all-time highs. Crude oil recovered slightly in Friday’s session and is back just…